⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Recover Investment Losses: Class Action Initiated Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Pomerantz LLP Informs Shareholders of Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
ROSEN, A LONGSTANDING LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Pomerantz LLP Informs Shareholders of Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
SPRY CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Class Action Lawsuit Alert: Levi & Korsinsky Reminds ARS Pharmaceuticals, Inc. (SPRY) Investors of October 5, 2026 Deadline
accessnewswire.com
SPRY
Pomerantz LLP Notifies Investors of Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Contact Levi & Korsinsky by October 5, 2026 to Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
ROSEN, A TOP RANKED LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Investor Alert: Deadline Approaching to Join ARS Pharmaceuticals, Inc. (SPRY) Class Action - Contact Levi & Korsinsky
accessnewswire.com
SPRY